2009 H1N1 influenza: a twenty-first century pandemic with roots in the early twentieth century
- PMID: 20697263
- PMCID: PMC7119454
- DOI: 10.1097/MAJ.0b013e3181e937b0
2009 H1N1 influenza: a twenty-first century pandemic with roots in the early twentieth century
Abstract
A swine-origin H1N1 triple-reassortant influenza A virus found to be a distant relative of the 1918 "Spanish flu" virus emerged in April 2009 to give rise to the first influenza pandemic of the 21st century. Although disease was generally mild and similar to seasonal influenza, severe manifestations including respiratory failure were noted in some, particularly those with underlying conditions such as asthma, pregnancy and immunosuppression. Children and younger adults accounted for most cases, hospitalizations and deaths. A reverse transcriptase-polymerase chain reaction assay was superior to antigen-based rapid tests for diagnosis. All 2009 H1N1 pandemic influenza strains were susceptible to 1 or more neuraminidase inhibitors. Monovalent, unadjuvanted 2009 H1N1 vaccines were licensed in the United States in September 2009 and initially targeted to younger individuals, pregnant women, caretakers of infants and healthcare providers. The 2009 H1N1 pandemic highlights the need for modernization of influenza vaccines, improved diagnostics and more rigorous evaluation of mitigation strategies.
Figures


Similar articles
-
Pandemic novel 2009 H1N1 influenza: what have we learned?Semin Respir Crit Care Med. 2011 Aug;32(4):393-9. doi: 10.1055/s-0031-1283279. Epub 2011 Aug 19. Semin Respir Crit Care Med. 2011. PMID: 21858744 Review.
-
[H1N1 influenza - pandemic, 2009].Orv Hetil. 2009 Dec 13;150(50):2265-73. doi: 10.1556/OH.2009.28766. Orv Hetil. 2009. PMID: 19951858 Hungarian.
-
Pandemic influenza A (H1N1) 2009: the experience of the first six months.Clin Chem Lab Med. 2010;48(1):11-21. doi: 10.1515/CCLM.2010.023. Clin Chem Lab Med. 2010. PMID: 20025556 Review.
-
[Virological characteristics of pandemic (H1N1) 2009 influenza virus].Uirusu. 2010 Jun;60(1):3-8. doi: 10.2222/jsv.60.3. Uirusu. 2010. PMID: 20848859 Review. Japanese.
-
An influenza A H1N1 virus revival - pandemic H1N1/09 virus.Infection. 2009 Oct;37(5):381-9. doi: 10.1007/s15010-009-9181-5. Epub 2009 Sep 18. Infection. 2009. PMID: 19768379 Review.
Cited by
-
B cell responses to the 2011/12-influenza vaccine in the aged.Aging (Albany NY). 2013 Mar;5(3):209-26. doi: 10.18632/aging.100541. Aging (Albany NY). 2013. PMID: 23674565 Free PMC article.
-
2009 Pandemic Influenza A (H1N1): Diagnosis, Management, and Prevention- Lessons Learned.Curr Infect Dis Rep. 2011 Apr;13(2):169-74. doi: 10.1007/s11908-010-0157-5. Curr Infect Dis Rep. 2011. PMID: 21365380
-
A comprehensive review on antimicrobial face masks: an emerging weapon in fighting pandemics.RSC Adv. 2021 Feb 8;11(12):6544-6576. doi: 10.1039/d0ra10009a. eCollection 2021 Feb 4. RSC Adv. 2021. PMID: 35423213 Free PMC article. Review.
-
Asthma and pregnancy.Clin Rev Allergy Immunol. 2012 Aug;43(1-2):45-56. doi: 10.1007/s12016-011-8277-8. Clin Rev Allergy Immunol. 2012. PMID: 21858482 Review.
-
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.Nat Commun. 2024 May 23;15(1):4350. doi: 10.1038/s41467-024-48555-z. Nat Commun. 2024. PMID: 38782954 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC) Isolation of avian influenza A (H5N1) viruses from humans—Hong Kong, May-December 1997. MMWR Morb Mortal Wkly Rep. 1997;46:1204–1207. - PubMed
-
- Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;25:2605–2615. - PubMed
-
- Zimmer S.M., Burke D.S. Historical perspective—emergence of influenza A (H11N1) viruses. N Engl J Med. 2009;361:279–285. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous